These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9499188

  • 21. Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation.
    Edelman MJ, Meyers FJ, Miller TR, Williams SG, Gandour-Edwards R, deVere White RW.
    Urology; 2000 Apr; 55(4):521-5. PubMed ID: 10736495
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interim fluorine-18 fluorodeoxyglucose positron emission tomography for early metabolic assessment of therapeutic response to chemotherapy for metastatic transitional cell carcinoma.
    Giannatempo P, Alessi A, Miceli R, Raggi D, Farè E, Nicolai N, Serafini G, Padovano B, Piva L, Biasoni D, Torelli T, Catanzaro M, Stagni S, Maffezzini M, Mariani L, Gianni AM, Sonpavde G, Salvioni R, Necchi A, Crippa F.
    Clin Genitourin Cancer; 2014 Dec; 12(6):433-9. PubMed ID: 24787972
    [Abstract] [Full Text] [Related]

  • 30. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.
    Lancet; 1999 Aug 14; 354(9178):533-40. PubMed ID: 10470696
    [Abstract] [Full Text] [Related]

  • 31. Combination chemotherapy for metastatic urinary bladder cancer with 5-FU, vincristine, bleomycin, cyclophosphamide, mitomycin, and methotrexate.
    Kubota Y, Shuin T, Miura T, Moriyama M, Fukushima S, Shiozaki H, Ooshima H.
    Cancer Treat Rep; 1984 Sep 14; 68(9):1167-8. PubMed ID: 6206946
    [Abstract] [Full Text] [Related]

  • 32. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
    Konami T, Wakabayashi Y, Kim T, Ishida A, Arai Y, Konishi T, Pak K, Takeuchi H, Tomoyoshi T, Watanabe J.
    Hinyokika Kiyo; 1989 Feb 14; 35(2):231-7. PubMed ID: 2472048
    [Abstract] [Full Text] [Related]

  • 33. [M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
    Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Nakatsu H, Kume T, Kodama M, Masu C.
    Hinyokika Kiyo; 1989 Aug 14; 35(8):1323-7. PubMed ID: 2683648
    [Abstract] [Full Text] [Related]

  • 34. [Conservative treatment of infiltrating cancer of the bladder: neoadjuvant chemotherapy and radiotherapy].
    Prié L, Gaston R, Ferrière JM, Richaud P, Bui BN, Guillou ML.
    Cancer Radiother; 1998 Apr 14; 2 Suppl 1():62s-66s. PubMed ID: 9749081
    [Abstract] [Full Text] [Related]

  • 35. First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.
    Bafaloukos D, Samonis G, Klinaki A, Daliani D, Karvounis N, Bacoyiannis C, Karabelis A, Milonakis N, Kosmidis P.
    Eur J Cancer; 1993 Apr 14; 29A(6):851-3. PubMed ID: 8484975
    [Abstract] [Full Text] [Related]

  • 36. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium.
    Dreicer R, Manola J, Roth BJ, See WA, Kuross S, Edelman MJ, Hudes GR, Wilding G.
    Cancer; 2004 Apr 15; 100(8):1639-45. PubMed ID: 15073851
    [Abstract] [Full Text] [Related]

  • 37. Intensive chemotherapy with cisplatin, mitoxantrone, methotrexate and vincristine in metastatic breast cancer.
    Queirolo P, Repetto L, Gardin G, Miglietta L, Guido T, Pronzato P, Rosso R.
    J Chemother; 1991 Jun 15; 3(3):194-7. PubMed ID: 1919659
    [Abstract] [Full Text] [Related]

  • 38. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F, Comella P, Marcolin P, Russo Spena F, Biglietto M, Cartenì G, De Lucia L, Avallone A, Gravina A, Comella G.
    Cancer; 1999 Feb 15; 85(4):952-9. PubMed ID: 10091775
    [Abstract] [Full Text] [Related]

  • 39. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD, Jolivet J, Birch R, Hopkins LG, Greco FA.
    Cancer; 1997 Feb 15; 79(4):740-8. PubMed ID: 9024712
    [Abstract] [Full Text] [Related]

  • 40. Carboplatin-based chemotherapy for bladder cancer.
    Waxman J, Barton C.
    Cancer Treat Rev; 1993 Feb 15; 19 Suppl C():21-5. PubMed ID: 8221712
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.